Sreoshi Chatterjee, Author at Pharma Journalist - Page 22 of 46

Arrowhead Pharmaceuticals seeks Orphan Drug Designation for ARO-AAT

Banyan Biomarkers attained FDA’s De Novo request for Banyan BTI

Celgene Corporation asserted OTEZLA’s Phase II Clinical Trial data

Arterys sought FDA clearance for Oncology AI suite

Viz.ai sought De Novo FDA clearance for LVO strokes in CTA imaging

DreaMed Diabetics attained CE Mark for Platform tackling Type 1 diabetes

Evofem Biosciences completes enrollment in Phase 3 Clinical Trial for Amphora

Citius enrolls first patient in Mino-Lok Phase 3 Clinical trial

Eisai asserts positive results of Phase 3 Study for lenvatinib mesylate

Merck KGaA and Pfizer assert Phase III JAVELIN Lung 200 trial results